Biogen has initiated the BRAVE study, a global Phase 3 clinical trial to evaluate omaveloxolone in children with Friedreich ataxia, addressing a critical unmet need in the pediatric population.

Akebia Therapeutics, Inc. (NASDAQ:AKBA) is one of the 12 Small Cap Stocks with High Upside Potential. On June 4, the company published pre-specified analyses for its vadadustat global phase 3 ...

"We are extremely excited to begin our global Phase 3 program in common warts, which has the potential to transform our company by expanding YCANTH’s label to one of the most prevalent skin conditions ...

Health Mission Karnataka: Ashakirana Phase 3 to set up 393 vision centres across the state to combat cataracts and refractive errors.

In his latest newsletter, Dr Karan Rajan reveals the nutrition crisis many of us are facing.

We take a deep dive into the inner workings of the wildly popular AI chatbot, ChatGPT. If you want to know how its generative AI magic happens, read on.